Aminopyrimidine derivatives as LRRK2 modulators
Compounds of the formula I:or pharmaceutically acceptable salts thereof,wherein m, n. X, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
Genentech, Inc.
C C C C C A C C A C
C07D C07D C07D C07D C07D A61P C07D C07D A61P C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Anthony Charles Daniel Huifen Zachary Kevin Mark Bryan K.
Estrada Baker-Glenn Shore Chen Sweeney Chambers Chan